The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Inhibition of HIV Activation in Latently Infected Cells by Flavonoid Compounds
Abstract
Acute HIV-1 infection of H9 and C8166 cultures has been shown to be suppressed by certain flavonoids, and evidence for inhibition of HIV-1 protease, integrase, and reverse transcriptase by flavonoids also exists. The present aim was to determine whether flavonoids inhibit HIV-1 activation in models of latent infection. By screening flavonoids from six different classes, three structurally related compounds (chrysin, acacetin, and apigenin) were identified that inhibited HIV expression in TNF-alpha-treated OM-10.1 cultures. The three compounds had favorable potencies against HIV activation in relation to their growth inhibitory effects (therapeutic index 5-10). Chrysin also inhibited HIV expression in response to PMA in OM-10.1 cells, in ACH-2 cells stimulated with either TNF-alpha or PMA, and in 8E5 cultures. Furthermore, return to viral latency in OM-10.1 cells previously exposed to TNF-alpha occurred over a shorter time interval when chrysin was added. The inhibition of HIV activation was not dependent on preincubation with flavonoids relative to TNF, and was characterized by a lack of HIV RNA accumulation by Northern analysis. Gel-shift experiments revealed that NF-kappa B activation after TNF-alpha treatment was not inhibited by these agents, suggesting that some other critical factor(s) needed for viral transcription was being affected. These findings indicate that flavonoids inhibit HIV-1 activation via a novel mechanism, and that these agents are potential candidates for therapeutic strategies aimed at maintaining a cellular state of HIV-1 latency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Cited by
Plant Products as Antimicrobial Agents
Cowan, M. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.4.564 · Cited by 9,043
“can look for cytopathic effects or plaque formation (1, 111) or for transformation or proliferative effects on cell lines (48).”
BackgroundChemistry and Biological Activities of Flavonoids: An Overview
Kumar, S., & Pandey, A. K. (2013) · The Scientific World Journal · doi:10.1155/2013/162750 · Cited by 4,980
Functional Properties of Honey, Propolis, and Royal Jelly
Viuda‐Martos, M., Ruiz‐Navajas, Y., Fernández‐López, J., & Pérez‐Álvarez, J. A. (2008) · Journal of Food Science · doi:10.1111/j.1750-3841.2008.00966.x · Cited by 864
Shafey, A. M. E. (2020) · Green Processing and Synthesis · doi:10.1515/gps-2020-0031 · Cited by 838
Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering
Nabavi, S. M., Šamec, D., Tomczyk, M., Milella, L., Russo, D., Habtemariam, S., Suntar, I., Rastrelli, L., Daglia, M., Xiao, J., et al. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.005 · Cited by 664
Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action
Mani, R., & Natesan, V. (2018) · Phytochemistry · doi:10.1016/j.phytochem.2017.09.016 · Cited by 461
Wang, D., Westerheide, S. D., Hanson, J. L., & Baldwin, A. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001358200 · Cited by 454
Flavonoids with Gastroprotective Activity
De Lira Mota, K. S., Dias, G. E. N., Pinto, M. E. F., Luiz-Ferreira, Â., Monteiro Souza-Brito, A. R., Hiruma-Lima, C. A., Barbosa-Filho, J. M., & Batista, L. M. (2009) · Molecules · doi:10.3390/molecules14030979 · Cited by 421
Flavonoids: Prospective Drug Candidates
Cazarolli, L., Zanatta, L., Alberton, E., Bonorino Figueiredo, M. S., Folador, P., Damazio, R., Pizzolatti, M., & Barreto Silva, F. R. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369564 · Cited by 404
Biosynthesis of Metal and Metal Oxide Nanoparticles
Jeevanandam, J., Chan, Y. S., & Danquah, M. K. (2016) · ChemBioEng Reviews · doi:10.1002/cben.201500018 · Cited by 374
Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection
De Clercq, E. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200009)20:5<323::aid-med1>3.0.co;2-a · Cited by 355
Bioflavonoids as antiradicals, antioxidants and DNA cleavage protectors
Russo, A., Acquaviva, R., Campisi, A., Sorrenti, V., Di Giacomo, C., Virgata, G., Barcellona, M. L., & Vanella, A. (2000) · Cell Biology and Toxicology · doi:10.1023/a:1007685909018 · Cited by 346
Health functionality of apigenin: A review
Ali, F., Rahul, Naz, F., Jyoti, S., & Siddique, Y. H. (2017) · International Journal of Food Properties · doi:10.1080/10942912.2016.1207188 · Cited by 343
Medicinal Plants, Human Health and Biodiversity: A Broad Review
Sen, T., & Samanta, S. K. (2014) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2014_273 · Cited by 330
Apoptotic Effects of Chrysin in Human Cancer Cell Lines
Khoo, B. Y., Chua, S. L., & Balaram, P. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11052188 · Cited by 304
Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives
Kasala, E. R., Bodduluru, L. N., Madana, R. M., V, A. K., Gogoi, R., & Barua, C. C. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.01.008 · Cited by 262
Role of phenolic compounds in peptic ulcer: An overview
Akhtar, M., Sumbul, S., Ahmad, M. A., & Asif, M. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.84437 · Cited by 257
Izuta, H., Shimazawa, M., Tazawa, S., Araki, Y., Mishima, S., & Hara, H. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf8014206 · Cited by 93
Metadata
- Authors
- CRITCHFIELD, J. W., BUTERA, S. T., & FOLKS, T. M.
- Venue
- AIDS Research and Human Retroviruses
- Publisher
- SAGE Publications
- Published
- 1996-01
- Volume
- 12
- Issue
- 1
- Pages
- 39-46
- ISSN
- 0889-2229 (ISSN-L)
- 1931-8405
- OpenAlex
- W2020351001
- Cited by
- 179
- References
- 1
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.